2022
DOI: 10.1016/j.jaad.2021.09.072
|View full text |Cite
|
Sign up to set email alerts
|

Early-onset effluvium secondary to COVID-19: Clinical and histologic characterization

Abstract: Early-onset effluvium secondary to COVID-19: Clinical and histologic characterizationTo the Editor: As telogen effluvium (TE) is the most common manifestation of postacute COVID-19 syndrome, we read with keen interest the publication by Abrantes et al 1 reporting the clinical characteristics of 30 patients with post-COVIDe19 acute TE. We would like to commend the authors and bring some other elements to this relevant discussion.TE is a heterogeneous condition that can be elicited by multiple stimuli. 2 Heading… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
7
0
3

Year Published

2022
2022
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(11 citation statements)
references
References 6 publications
1
7
0
3
Order By: Relevance
“…To the Editor: We agree with the points made by Miola et al 1 about the possibility of dystrophic anagen effluvium in cases assumed to be diagnosed with acute telogen effluvium, particularly in more severe hospitalized cases, when associated with early onset.…”
supporting
confidence: 73%
See 1 more Smart Citation
“…To the Editor: We agree with the points made by Miola et al 1 about the possibility of dystrophic anagen effluvium in cases assumed to be diagnosed with acute telogen effluvium, particularly in more severe hospitalized cases, when associated with early onset.…”
supporting
confidence: 73%
“…As pointed out, some scalp biopsies showed no evidence of inflammation. 1 Thus, in the context of therapeutic initiation for COVID-19, therapy could have a benefit by halting respiratory involvement progression, improving oxygenation and physical stress, thus preserving the homeostasis of multiple organs, including the skin.…”
mentioning
confidence: 99%
“…Table 2 delineates the demographics and clinical characteristics of patients with hair loss and COVID‐19 ( n = 58), with a predominance of female patients (17.2% male and 82.8% female). 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 Hair loss type was predominately TE (74.1%), with the next most common hair loss type being early‐onset effluvium (12.1%). Only a small number of individuals had other types of hair loss including AA (5.2%), fibrosing alopecia (3.4%), and one individual each with alopecia areata totalis (1.7%), alopecia areata universalis (1.7%), and anagen effluvium (1.7%).…”
Section: Resultsmentioning
confidence: 99%
“…Как понимание того, каким образом патологическая динамика потери волос связана с циклом роста волос и целостностью волосяного фолликула, так и понимание того, что у нарушений, связанных с потерей волос, может существовать множество причин, являются предпосылкой для оказания соответствующей помощи пациенту. Анализируя причинно-следственные связи при «постковидной» алопеции, необходимо обратить внимание на целый комплекс факторов, воздействующих на волосяной фолликул [7][8][9].…”
Section: этиология и патогенез телогеновых алопецийunclassified